Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer - Related Studies

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

This study has been terminated.

Study NCT00080028. Last updated on May 4, 2007. Information provided by Pharmacyclics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer
		Oropharynx Cancer
		Larynx Cancer
		Hypopharynx Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Hypopharyngeal Neoplasms
		Laryngeal Neoplasms
		Oropharyngeal Neoplasms

3	More general conditions related to this trial
		Laryngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		Motexafin Gadolinium Injection

5	Additional drug interventions recognized in this trial
		Motexafin gadolinium

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Dermatologic Agents
		Pharmacologic Actions
		Photosensitizing Agents
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Pharmacyclics